EDITORIAL		Better Safe Than Sorry Does reducing viral load reduce the risk of transmitting HIV? PAUL A. VOLBERDING, M.D.
THERAPEUTIC ADVANCES		The Next Generation of Antiretroviral Agents Potent and promising new drugs will soon be available to combat HIV infection HAROLD A. KESSLER, M.D.
NEWSLINE		NEWSLINE ... NEWSLINE ... NEWSLINE ... Fomivirsen proves effective against CMV retinitis ... Patients are warned not to resume taking abacavir if they have an allergic reaction to it ... d4T plus 3TC, a therapeutic option in people who develop resistance to AZT ... "Protease paunch" and "buffalo hump": Combination therapy can lead to unusual fatty deposits ... Sustiva^® now available to anyone with a CD4 count below 400 ... HAART therapy leads to resolution of MAC infection ... Plus: what this means for you: HIV experts tell you, in clear, concise language, what impact these developments are likely to have on your day-to-day life. Advertisement
PULL OUT AND SAVE		Clinical Trials You May Wish to Enroll In A list of current clinical trials that involve various combinations of anti-HIV drugs, some of which cannot otherwise be obtained by people living with HIV infection
CONTINUING CARE		Better Treatment for CMV Retinitis New drugs and new strategies can slow disease progression MARK A. JACOBSON, M.D.

This article was provided by San Francisco General Hospital. It is a part of the publication AIDS Care.

10 Questions to Ask Yourself Before You Begin HIV Treatment

Getting to Undetectable: People Living With HIV Share Their Stories

HIV Management Today: Mental Health & HIV, the Uncharted Territory

Let's Talk About the HIV Cure News: A Blog Entry by Warren Tong

Get TheBody.com in the Palm of Your Hand

More >>

New! TheBody.com App

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.

Table of Contents

EDITORIAL

Better Safe Than Sorry

THERAPEUTIC ADVANCES

The Next Generation of Antiretroviral Agents

NEWSLINE

NEWSLINE ... NEWSLINE ... NEWSLINE ...

PULL OUT AND SAVE

Clinical Trials You May Wish to Enroll In

CONTINUING CARE

Better Treatment for CMV Retinitis